BREAKING: FDA advisers recommend that the agency approve the country’s first RSV vaccine for older people, a shot from Pfizer for adults ages 60 and up. https://t.co/LvWVqqUGwT— NBC News (@NBCNews) February 28, 2023
BREAKING: FDA advisers recommend that the agency approve the country’s first RSV vaccine for older people, a shot from Pfizer for adults ages 60 and up. https://t.co/LvWVqqUGwT